Futura Medical Issues Circular and Schedules General Meeting on 23 September 2026 to Approve Capital Raise

Futura Medical Issues Circular and Schedules General Meeting on 23 September 2026 to Approve Capital Raise →

Futura Medical plc (AIM: FUM), the AIM-listed consumer healthcare company behind the erectile dysfunction gel Eroxon® , has sent a Circular and Notice of General Meeting to shareholders following its fundraise announcement on 3 September 20…